These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 28935714)
1. Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells. Draheim M; Wlodarczyk MF; Crozat K; Saliou JM; Alayi TD; Tomavo S; Hassan A; Salvioni A; Demarta-Gatsi C; Sidney J; Sette A; Dalod M; Berry A; Silvie O; Blanchard N EMBO Mol Med; 2017 Nov; 9(11):1605-1621. PubMed ID: 28935714 [TBL] [Abstract][Full Text] [Related]
2. Development of a Novel CD4 Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838 [TBL] [Abstract][Full Text] [Related]
3. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. Lemos MP; Esquivel F; Scott P; Laufer TM J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255 [TBL] [Abstract][Full Text] [Related]
4. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Lundie RJ; de Koning-Ward TF; Davey GM; Nie CQ; Hansen DS; Lau LS; Mintern JD; Belz GT; Schofield L; Carbone FR; Villadangos JA; Crabb BS; Heath WR Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14509-14. PubMed ID: 18799734 [TBL] [Abstract][Full Text] [Related]
5. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity. Lemos MP; Fan L; Lo D; Laufer TM J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905 [TBL] [Abstract][Full Text] [Related]
6. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Nie CQ; Bernard NJ; Schofield L; Hansen DS Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053 [TBL] [Abstract][Full Text] [Related]
7. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains. Machy P; Serre K; Baillet M; Leserman L J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652 [TBL] [Abstract][Full Text] [Related]
8. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype. Buatois V; Baillet M; Bécart S; Mooney N; Leserman L; Machy P J Immunol; 2003 Dec; 171(11):5812-9. PubMed ID: 14634090 [TBL] [Abstract][Full Text] [Related]
10. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner. Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N mBio; 2020 Apr; 11(2):. PubMed ID: 32265335 [TBL] [Abstract][Full Text] [Related]
11. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy. Teramoto K; Ohshio Y; Fujita T; Hanaoka J; Kontani K J Cancer Res Clin Oncol; 2013 May; 139(5):861-70. PubMed ID: 23411688 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Langhorne J; Albano FR; Hensmann M; Sanni L; Cadman E; Voisine C; Sponaas AM Immunol Rev; 2004 Oct; 201():35-47. PubMed ID: 15361231 [TBL] [Abstract][Full Text] [Related]
14. NK1.1 Expression Defines a Population of CD4 Wikenheiser DJ; Brown SL; Lee J; Stumhofer JS Front Immunol; 2018; 9():2277. PubMed ID: 30374346 [TBL] [Abstract][Full Text] [Related]
15. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines. Dobaño C; Rogers WO; Gowda K; Doolan DL Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849 [TBL] [Abstract][Full Text] [Related]
16. Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Heide J; Wildner NH; Ackermann C; Wittner M; Marget M; Sette A; Sidney J; Jacobs T; Schulze Zur Wiesch J Front Immunol; 2019; 10():3037. PubMed ID: 32038611 [No Abstract] [Full Text] [Related]
17. Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells. Mantegazza AR; Guttentag SH; El-Benna J; Sasai M; Iwasaki A; Shen H; Laufer TM; Marks MS Immunity; 2012 May; 36(5):782-94. PubMed ID: 22560444 [TBL] [Abstract][Full Text] [Related]
18. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells. Schlecht G; Leclerc C; Dadaglio G J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742 [TBL] [Abstract][Full Text] [Related]
19. Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection. Sponaas AM; Belyaev N; Falck-Hansen M; Potocnik A; Langhorne J Infect Immun; 2012 Dec; 80(12):4248-56. PubMed ID: 23006847 [TBL] [Abstract][Full Text] [Related]